GROUP PSYCHOSOCIAL THERAPY (GPT) + TAU vs TAU
Mental state · Adolescents with psychosis
1 finding from 1 review
- no estimate extracted1 study · 56 participantsVery low
Findings
What do systematic reviews say?
217 questions · 227 findings · 49 reviews · Schizophrenia
No studies found 5 · 2.2%GRADE not reported 12 · 5.3%Very low 105 · 46.3%Low 46 · 20.3%Moderate 57 · 25.1%High 2 · 0.9%
Avatar Therapy vs treatment
Mental state: 2. Positive symptoms ‐ average endpoint score PANSS positive subscore · schizophrenia or related disorders
1 finding from 1 review
- Avatar Therapy for people with schizophrenia or related disorders 2020 · Cochrane Headline outcomes onlyno estimate extracted1 study · 19 participantsVery low
Avatar Therapy vs supportive counselling (all short‐term)
Quality of Life Manchester Short Assessment (MANSA) · schizophrenia or related disorders
1 finding from 1 review
- Avatar Therapy for people with schizophrenia or related disorders 2020 · Cochrane Headline outcomes onlyno estimate extracted1 study · 120 participantsLow
Avatar Therapy vs treatment
Mental state: specific – insight – average attitude to voices score (BAVQ‐R, high = poor) – short term · schizophrenia or related disorders
1 finding from 1 review
- Avatar Therapy for people with schizophrenia or related disorders 2020 · Cochrane Headline outcomes onlyno estimate extracted1 study · 19 participantsVery low
Avatar Therapy vs treatment
QoL · schizophrenia or related disorders
1 finding from 1 review
- Avatar Therapy for people with schizophrenia or related disorders 2020 · Cochrane Headline outcomes onlyno estimate extracted1 study · 19 participantsVery low
Avatar Therapy vs supportive counselling (all short‐term)
Mental state · schizophrenia or related disorders
1 finding from 1 review
- Avatar Therapy for people with schizophrenia or related disorders 2020 · Cochrane Headline outcomes onlyno estimate extracted1 study · 124 participantsLow
Avatar Therapy vs supportive counselling (all short‐term)
Mental state: specific – insight – average attitude to voices score (BAVQ‐R, high = poor) – short term · schizophrenia or related disorders
1 finding from 1 review
- Avatar Therapy for people with schizophrenia or related disorders 2020 · Cochrane Headline outcomes onlyno estimate extracted1 study · 124 participantsLow
Non‐integrated models of care ‐ Assertive community treatment only/Intensive case management/Specialised case management services vs usual care
Global State: Average score (Role Functioning Scale, high = better functioning) · people with both severe mental illness and substance misuse
1 finding from 1 review
- Psychosocial interventions for people with both severe mental illness and substance misuse 2019 · Cochrane Headline outcomes onlyno estimate extracted1 study · 50 participantsVery low
ECT plus standard care vs antipsychotics plus standard care
Mental state · people with treatment‐resistant schizophrenia
1 finding from 1 review
- Electroconvulsive therapy for treatment‐resistant schizophrenia 2019 · Cochrane Headline outcomes onlyno estimate extracted1 study · 162 participantsVery low
ECT plus standard care vs usual care
Mental state · people with treatment‐resistant schizophrenia
1 finding from 1 review
- Electroconvulsive therapy for treatment‐resistant schizophrenia 2019 · Cochrane Headline outcomes onlyno estimate extracted2 studies · 345 participantsLow
ECT plus standard care vs usual care
General functioning: Average endpoint general functioning score (clinically improved) (no data) · people with treatment‐resistant schizophrenia
1 finding from 1 review
- Electroconvulsive therapy for treatment‐resistant schizophrenia 2019 · Cochrane Headline outcomes onlyno estimate extracted2 studies · 97 participantsVery low
ECT alone vs antipsychotics
Mental state · people with treatment‐resistant schizophrenia
1 finding from 1 review
- Electroconvulsive therapy for treatment‐resistant schizophrenia 2019 · Cochrane Headline outcomes onlyno estimate extracted1 study · 30 participantsVery low
ECT alone vs antipsychotics
General functioning: Average endpoint general functioning score (clinically improved) (no data) · people with treatment‐resistant schizophrenia
1 finding from 1 review
- Electroconvulsive therapy for treatment‐resistant schizophrenia 2019 · Cochrane Headline outcomes onlyno estimate extracted1 study · 30 participantsVery low
ECT plus standard care vs sham‐ECT plus standard care
Mental state · people with treatment‐resistant schizophrenia
1 finding from 1 review
- Electroconvulsive therapy for treatment‐resistant schizophrenia 2019 · Cochrane Headline outcomes onlyno estimate extracted1 study · 25 participantsVery low
Aspirin plus antipsychotics vs placebo/no adjunctive treatment + antipsychotics
Clinical response: mean score/change in mental state: mean PANSS total score (high = poor) · patients with schizophrenia
1 finding from 1 review
- no estimate extracted2 studies · 130 participantsVery low
Omega‐3 vs placebo
Mental state: psychotic symptoms Average total score (PANSS, higher score = worse, scale from 30‐210) Long‐term (up to 7 years) · people in the prodromal stage of psychosis
1 finding from 1 review
- no estimate extracted1 study · 81 participantsLow
Group B antipsychotic drugs: olanzapine + supportive intervention vs placebo or supportive treatment
Global effect: 1a. Medium‐term ‐ Average end point score on various outcomes ‐ CGI‐severity (low = favourable) ( · people in the prodromal stage of psychosis
1 finding from 1 review
- no estimate extracted1 study · 59 participantsVery low
Group B antipsychotic drugs: olanzapine + supportive intervention vs placebo or supportive treatment
Mental state: psychosis risk symptoms SOPS total (higher score = worse, scale from: 0‐114) · people in the prodromal stage of psychosis
1 finding from 1 review
- no estimate extracted1 study · 59 participantsVery low
Group B antipsychotic drugs: olanzapine + supportive intervention vs placebo or supportive treatment
Weight gain · people in the prodromal stage of psychosis
1 finding from 1 review
- no estimate extracted1 study · 59 participantsVery low
Group A: amino acids vs placebo
Mental state: psychosis risk symptoms SOPS total (higher score = worse, scale from: 0‐114) · people in the prodromal stage of psychosis
1 finding from 1 review
- no estimate extracted1 study · 8 participantsVery low